State Street’s AIM ImmunoTech AIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,733
Closed -$21.2K 4368
2025
Q1
$21.2K Hold
1,733
﹤0.01% 4200
2024
Q4
$34.3K Hold
1,733
﹤0.01% 4168
2024
Q3
$46.7K Hold
1,733
﹤0.01% 4113
2024
Q2
$64.5K Hold
1,733
﹤0.01% 4098
2024
Q1
$81.5K Hold
1,733
﹤0.01% 4065
2023
Q4
$76.1K Hold
1,733
﹤0.01% 4110
2023
Q3
$78.8K Hold
1,733
﹤0.01% 4169
2023
Q2
$116K Hold
1,733
﹤0.01% 4194
2023
Q1
$74.4K Hold
1,733
﹤0.01% 4405
2022
Q4
$54K Hold
1,733
﹤0.01% 4543
2022
Q3
$101K Hold
1,733
﹤0.01% 4463
2022
Q2
$135K Hold
1,733
﹤0.01% 4377
2022
Q1
$183K Buy
1,733
+127
+8% +$10.9K ﹤0.01% 4412
2021
Q4
$148K Hold
1,606
﹤0.01% 4468
2021
Q3
$324K Hold
1,606
﹤0.01% 4155
2021
Q2
$345K Buy
+1,606
New +$344K ﹤0.01% 3999
2016
Q3
Sell
-2
Closed -$9K 3717
2016
Q2
$9K Hold
2
﹤0.01% 3707
2016
Q1
$11K Hold
2
﹤0.01% 3701
2015
Q4
$7K Hold
2
﹤0.01% 3706
2015
Q3
$14K Hold
2
﹤0.01% 3683
2015
Q2
$16K Hold
2
﹤0.01% 3691
2015
Q1
$18K Hold
2
﹤0.01% 3647
2014
Q4
$21K Hold
2
﹤0.01% 3648
2014
Q3
$28K Hold
2
﹤0.01% 3627
2014
Q2
$28K Hold
2
﹤0.01% 3591
2014
Q1
$36K Hold
2
﹤0.01% 3583
2013
Q4
$24K Hold
2
﹤0.01% 3584
2013
Q3
$21K Hold
2
﹤0.01% 3585
2013
Q2
$19K Buy
+2
New +$23.9K ﹤0.01% 3527

Other funds holding AIM

State Street's AIM Position: Q2 2025 in Review

State Street sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 1,733 shares — an estimated $21.2K sold.

State Street first reported a position in AIM in Q2 2013 and held it in 29 quarters. The position peaked at $345K in Q2 2021. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • State Street reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • State Street sold 1,733 AIM ImmunoTech shares in Q2 2025, an estimated $21.2K.
  • State Street first reported a position in AIM ImmunoTech in Q2 2013 and held it in 29 quarters.
  • State Street's AIM ImmunoTech position peaked at $345K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.